SLC5A2 and diabetic kidney disease: 332 Liu Liu H H Sridhar Sridhar VS VS Boulet Boulet J J Dharia Dharia A A Khan Khan A A Lawler Lawler PR PR Cardiorenal Protection with SGLT2 Inhibitors in Patients with Diabetes Mellitus: From Biomarkers to Clinical Outcomes in Heart Failure and Diabetic Kidney Disease Cardiorenal Protection with SGLT2 Inhibitors in Patients with Diabetes Mellitus: From Biomarkers to Clinical Outcomes in Heart Failure and Diabetic Kidney Disease Metabolism Metabolism 2022; 2022; 126 126 154918 154918 154918 154918 10.1016/j.metabol.2021.154918 10.1016/j.metabol.2021.154918 34699838 34699838